RecruitingNCT06203093
Charcot-Marie-Tooth Disease (CMT) Biological Sample Collection for IPSC Generation and Biobanking
Studying Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- New York Stem Cell Foundation Research Institute
- Principal Investigator
- Laura Andres-MartinNew York Stem Cell Foundation Research Institute
- Intervention
- Biological Sample Collection(other)
- Enrollment
- 50 enrolled
- Eligibility
- 5 years · All sexes
- Timeline
- 2022 – 2025
Study locations (1)
- New York Stem Cell Foundation Research Institute, New York, New York, United States
Collaborators
Charcot-Marie-Tooth Association
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06203093 on ClinicalTrials.govOther trials for Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07038239Genotype/Phenotype Correlation of MORC2 MutationsHospices Civils de Lyon
- RECRUITINGNCT05902351Natural History Study for Charcot Marie Tooth DiseaseHereditary Neuropathy Foundation
See all trials for Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons →